GlobalDeal

Selecta Biotech

Biotechnology · Zug, Switzerland

selectabiotech.com

About Selecta Biotech

Selecta Biotech is a clinical-stage biotechnology company focused on developing innovative therapies for patients with serious diseases. The company specializes in the development of immune tolerance therapies, particularly for the treatment of rare diseases and autoimmune disorders. Selecta's proprietary platform, ImmTOR, is designed to induce immune tolerance and improve the efficacy and safety of biologic therapies. The company is committed to advancing its pipeline of product candidates through clinical trials and collaborations with other biopharmaceutical companies.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Gene Therapy, Immunotherapy, Rare Diseases, Autoimmune Disorders
Location
Zug, Switzerland
Employees
11–50
Revenue (USD)
1–5M
Founded
2013

Products and services

Open Selecta Biotech in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Switzerland

All 636 Biotechnology companies in Switzerland →